Safety and efficacy of at-home robotic locomotion therapy in individuals with chronic incomplete spinal cord injury: a prospective, pre-post intervention, proof-of-concept study.

<h4>Background</h4>The compact Motorized orthosis for home rehabilitation of Gait (MoreGait) was developed for continuation of locomotion training at home. MoreGait generates afferent stimuli of walking with the user in a semi-supine position and provides feedback about deviations from t...

Full description

Bibliographic Details
Main Authors: Rüdiger Rupp, Daniel Schließmann, Harry Plewa, Christian Schuld, Hans Jürgen Gerner, Norbert Weidner, Eberhard P Hofer, Markus Knestel
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0119167
_version_ 1819028737524498432
author Rüdiger Rupp
Daniel Schließmann
Harry Plewa
Christian Schuld
Hans Jürgen Gerner
Norbert Weidner
Eberhard P Hofer
Markus Knestel
author_facet Rüdiger Rupp
Daniel Schließmann
Harry Plewa
Christian Schuld
Hans Jürgen Gerner
Norbert Weidner
Eberhard P Hofer
Markus Knestel
author_sort Rüdiger Rupp
collection DOAJ
description <h4>Background</h4>The compact Motorized orthosis for home rehabilitation of Gait (MoreGait) was developed for continuation of locomotion training at home. MoreGait generates afferent stimuli of walking with the user in a semi-supine position and provides feedback about deviations from the reference walking pattern.<h4>Objective</h4>Prospective, pre-post intervention, proof-of-concept study to test the feasibility of an unsupervised home-based application of five MoreGait prototypes in subjects with incomplete spinal cord injury (iSCI).<h4>Methods</h4>Twenty-five (5 tetraplegia, 20 paraplegia) participants with chronic (mean time since injury: 5.8 ± 5.4 (standard deviation, SD) years) sensorimotor iSCI (7 ASIA Impairment Scale (AIS) C, 18 AIS D; Walking Index for Spinal Cord Injury (WISCI II): Interquartile range 9 to 16) completed the training (45 minutes / day, at least 4 days / week, 8 weeks). Baseline status was documented 4 and 2 weeks before and at training onset. Training effects were assessed after 4 and 8 weeks of therapy.<h4>Results</h4>After therapy, 9 of 25 study participants improved with respect to the dependency on walking aids assessed by the WISCI II. For all individuals, the short-distance walking velocity measured by the 10-Meter Walk Test showed significant improvements compared to baseline (100%) for both self-selected (Mean 139.4% ± 35.5% (SD)) and maximum (Mean 143.1% ± 40.6% (SD)) speed conditions as well as the endurance estimated with the six-minute walk test (Mean 166.6% ± 72.1% (SD)). One device-related adverse event (pressure sore on the big toe) occurred in over 800 training sessions.<h4>Conclusions</h4>Home-based robotic locomotion training with MoreGait is feasible and safe. The magnitude of functional improvements achieved by MoreGait in individuals with iSCI is well within the range of complex locomotion robots used in hospitals. Thus, unsupervised MoreGait training potentially represents an option to prolong effective training aiming at recovery of locomotor function beyond in-patient rehabilitation.<h4>Trial registration</h4>German Clinical Trials Register (DKRS) DRKS00005587.
first_indexed 2024-12-21T06:03:07Z
format Article
id doaj.art-324bd20b34574a37aa8f594cfdfbb731
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T06:03:07Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-324bd20b34574a37aa8f594cfdfbb7312022-12-21T19:13:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01103e011916710.1371/journal.pone.0119167Safety and efficacy of at-home robotic locomotion therapy in individuals with chronic incomplete spinal cord injury: a prospective, pre-post intervention, proof-of-concept study.Rüdiger RuppDaniel SchließmannHarry PlewaChristian SchuldHans Jürgen GernerNorbert WeidnerEberhard P HoferMarkus Knestel<h4>Background</h4>The compact Motorized orthosis for home rehabilitation of Gait (MoreGait) was developed for continuation of locomotion training at home. MoreGait generates afferent stimuli of walking with the user in a semi-supine position and provides feedback about deviations from the reference walking pattern.<h4>Objective</h4>Prospective, pre-post intervention, proof-of-concept study to test the feasibility of an unsupervised home-based application of five MoreGait prototypes in subjects with incomplete spinal cord injury (iSCI).<h4>Methods</h4>Twenty-five (5 tetraplegia, 20 paraplegia) participants with chronic (mean time since injury: 5.8 ± 5.4 (standard deviation, SD) years) sensorimotor iSCI (7 ASIA Impairment Scale (AIS) C, 18 AIS D; Walking Index for Spinal Cord Injury (WISCI II): Interquartile range 9 to 16) completed the training (45 minutes / day, at least 4 days / week, 8 weeks). Baseline status was documented 4 and 2 weeks before and at training onset. Training effects were assessed after 4 and 8 weeks of therapy.<h4>Results</h4>After therapy, 9 of 25 study participants improved with respect to the dependency on walking aids assessed by the WISCI II. For all individuals, the short-distance walking velocity measured by the 10-Meter Walk Test showed significant improvements compared to baseline (100%) for both self-selected (Mean 139.4% ± 35.5% (SD)) and maximum (Mean 143.1% ± 40.6% (SD)) speed conditions as well as the endurance estimated with the six-minute walk test (Mean 166.6% ± 72.1% (SD)). One device-related adverse event (pressure sore on the big toe) occurred in over 800 training sessions.<h4>Conclusions</h4>Home-based robotic locomotion training with MoreGait is feasible and safe. The magnitude of functional improvements achieved by MoreGait in individuals with iSCI is well within the range of complex locomotion robots used in hospitals. Thus, unsupervised MoreGait training potentially represents an option to prolong effective training aiming at recovery of locomotor function beyond in-patient rehabilitation.<h4>Trial registration</h4>German Clinical Trials Register (DKRS) DRKS00005587.https://doi.org/10.1371/journal.pone.0119167
spellingShingle Rüdiger Rupp
Daniel Schließmann
Harry Plewa
Christian Schuld
Hans Jürgen Gerner
Norbert Weidner
Eberhard P Hofer
Markus Knestel
Safety and efficacy of at-home robotic locomotion therapy in individuals with chronic incomplete spinal cord injury: a prospective, pre-post intervention, proof-of-concept study.
PLoS ONE
title Safety and efficacy of at-home robotic locomotion therapy in individuals with chronic incomplete spinal cord injury: a prospective, pre-post intervention, proof-of-concept study.
title_full Safety and efficacy of at-home robotic locomotion therapy in individuals with chronic incomplete spinal cord injury: a prospective, pre-post intervention, proof-of-concept study.
title_fullStr Safety and efficacy of at-home robotic locomotion therapy in individuals with chronic incomplete spinal cord injury: a prospective, pre-post intervention, proof-of-concept study.
title_full_unstemmed Safety and efficacy of at-home robotic locomotion therapy in individuals with chronic incomplete spinal cord injury: a prospective, pre-post intervention, proof-of-concept study.
title_short Safety and efficacy of at-home robotic locomotion therapy in individuals with chronic incomplete spinal cord injury: a prospective, pre-post intervention, proof-of-concept study.
title_sort safety and efficacy of at home robotic locomotion therapy in individuals with chronic incomplete spinal cord injury a prospective pre post intervention proof of concept study
url https://doi.org/10.1371/journal.pone.0119167
work_keys_str_mv AT rudigerrupp safetyandefficacyofathomeroboticlocomotiontherapyinindividualswithchronicincompletespinalcordinjuryaprospectiveprepostinterventionproofofconceptstudy
AT danielschließmann safetyandefficacyofathomeroboticlocomotiontherapyinindividualswithchronicincompletespinalcordinjuryaprospectiveprepostinterventionproofofconceptstudy
AT harryplewa safetyandefficacyofathomeroboticlocomotiontherapyinindividualswithchronicincompletespinalcordinjuryaprospectiveprepostinterventionproofofconceptstudy
AT christianschuld safetyandefficacyofathomeroboticlocomotiontherapyinindividualswithchronicincompletespinalcordinjuryaprospectiveprepostinterventionproofofconceptstudy
AT hansjurgengerner safetyandefficacyofathomeroboticlocomotiontherapyinindividualswithchronicincompletespinalcordinjuryaprospectiveprepostinterventionproofofconceptstudy
AT norbertweidner safetyandefficacyofathomeroboticlocomotiontherapyinindividualswithchronicincompletespinalcordinjuryaprospectiveprepostinterventionproofofconceptstudy
AT eberhardphofer safetyandefficacyofathomeroboticlocomotiontherapyinindividualswithchronicincompletespinalcordinjuryaprospectiveprepostinterventionproofofconceptstudy
AT markusknestel safetyandefficacyofathomeroboticlocomotiontherapyinindividualswithchronicincompletespinalcordinjuryaprospectiveprepostinterventionproofofconceptstudy